Literature DB >> 32220227

Case report: a 58 -year -old man with small kidneys and elevated liver enzymes.

Jonathan Dash1, Patrick Saudan2, Ariane Paoloni-Giacobino3, Solange Moll4, Sophie de Seigneux2.   

Abstract

BACKGROUND: The conjunction of hepatitis and renal disease can be seen in several clinical context, including karyomegalic nephritis (KIN). Karyomegalic nephritis (KIN) is a rare genetic disease, with less than 50 cases reported, which incidence is probably underestimated. We report here an unusual case presentation of KIN with obtention of several organ biopsies and a novel mutation leading to the disease. CASE
PRESENTATION: A 58 year old Caucasian without relevant family history presents with advanced chronic kidney disease, elevated liver enzymes and recurrent pulmonary infection. Familial history was negative. Renal biopsy revealed a chronic tubulo-intertsitial nephritis with enlarged and irregular hyperchromatic nuclei. Karyomegalic nephritis (KIN) was confirmed by genetic testing with a non-sense mutation and a deletion in the Fanconi anemia associated nuclease 1 (FAN1) gene.
CONCLUSIONS: KIN is rare disease to be suspected in the presence of renal disease, biological hepatitis and recurrent pulmonary infections, even without a familial history. Diagnosis of this condition is crucial to perform family screening, avoid progression factors, and adapt post transplantation immunosuppression. Finally, avoiding familial heterozygote donors appears of major importance in this condition.

Entities:  

Keywords:  Chronic kidney disease; Genetic; Karyomegalic interstitial nephritis

Year:  2020        PMID: 32220227     DOI: 10.1186/s12882-020-01762-4

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  1 in total

1.  New familial cases of karyomegalic interstitial nephritis with mutations in the FAN1 gene.

Authors:  Imen Rejeb; Mouna Jerbi; Houweyda Jilani; Hanène Gaied; Yasmina Elaribi; Syrine Hizem; Raja Aoudia; Hafedh Hedri; Chiraz Zaied; Salwa Abid; Hassen Bacha; Taieb BenAbdallah; Lamia BenJemaa; Rim Goucha
Journal:  BMC Med Genomics       Date:  2021-06-14       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.